Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof

Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof

US Patent 11638728 · Granted May 2, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Beta-catenin inhibitors in cancer immunotherapy2024
Methods and compositions related to T-cell activity2023
Dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment2023
Synergistic combination of immunologic inhibitors for the treatment of cancer2021
Methods and compositions related to T-cell activity2020
Beta-catenin inhibitors in cancer immunotherapy2020
Synergistic combination of immunologic inhibitors for the treatment of cancer2018
Methods and compositions related to T-cell activity2018
Treatment of cancer by manipulation of commensal microflora2018
T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase2008
Vaccine adjuvants for immunotherapy of melanoma2004
Isolated peptides derived from mage tumor rejection antigen precursors which com2004